ASXL1 and mastocytosis: It will be of prime importance to pursue future studies directed at analyzing which group of concurrent mutations (e.g. KIT-TET2-ASXL1), and their sequential onset in the course of disease evolution (e.g. KIT followed by TET2 followed by ASXL1) plays a role in establishing the severity of mastocytosis and survival of patients.